News
MSD is preparing to take on Takeda in the dengue fever vaccine market, moving its V181 candidate into phase 3.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback